Bone Grafting Techniques in Spinal Fusion

Spinal fusion represents a cornerstone of surgical management for degenerative, traumatic and deformity pathologies of the spine. Successful arthrodesis depends on the interplay of osteogenic cells, signalling molecules and a supportive matrix. Traditional autologous bone graft, typically harvested from the iliac crest, remains the benchmark due to its intrinsic osteogenic, osteoinductive and osteoconductive capacities, yet limitations in graft volume and donor-site morbidity have stimulated advances in graft substitutes. Allogeneic bone provides ready-to-use structural support, whereas demineralised bone matrix retains native growth factors to promote osteoinduction. Synthetic ceramics and polymers such as hydroxyapatite, tricalcium phosphate and polyetheretherketone (PEEK) have been refined to offer biocompatible, porous scaffolds optimised for mechanical load and cell infiltration. More recently, biologic enhancers including bone morphogenetic proteins, mesenchymal stem cell derivatives and platelet-rich plasma have emerged to boost osteogenesis and reduce non-union. Developments in scaffold architecture, growth factor release systems and cell-based therapies aim to lower pseudarthrosis rates and enhance fusion longevity across diverse clinical settings.

Research from Nature Portfolio

Recent preclinical investigations have explored composite graft formulations combining demineralised bone matrix with platelet-rich plasma and autologous bone marrow fluid in a posterolateral fusion model. These studies demonstrated that the addition of growth-factor-rich plasma and marrow constituents to a demineralised scaffold significantly accelerated bone bridging and increased mechanical strength, achieving complete union by eight weeks in animal models. A comprehensive systematic review and meta-analysis has evaluated clinical outcomes across graft types, revealing that local bone autograft offers superior fusion rates compared with allograft and synthetic alternatives, while allogeneic grafts show lower pseudarthrosis and adverse event profiles in some series. This synthesis underscores the need for standardised comparative trials to clarify optimal graft selection.

Bone Grafting Techniques in Spinal Fusion publication trend

The graph below shows the total number of articles in bone grafting techniques in spinal fusion across all publications each year (not limited to Nature Index journals).

Technical terms

Autologous bone graft: Bone tissue harvested from the same individual undergoing spinal fusion, providing osteogenic cells and native scaffolding.

Demineralised bone matrix (DBM): Allograft bone processed to remove mineral content while retaining collagen and growth factors for osteoinduction.

Osteoconduction: The ability of a scaffold to support the attachment and growth of new bone along its surface.

Osteoinduction: The stimulation of progenitor cells to differentiate into bone-forming osteoblasts via bioactive signals.

Osteogenesis: The process of new bone formation mediated by osteoblasts derived from progenitor cells.

Platelet-rich plasma (PRP): A concentrate of autologous platelets containing growth factors that can enhance tissue repair and bone healing.

Mesenchymal stem cell exosomes: Extracellular vesicles released by stromal cells that carry signalling molecules to promote osteogenesis.

Pseudarthrosis: A failure of spinal fusion resulting in a false joint due to incomplete bone union.

Posterolateral fusion: A spinal fusion technique placing graft material between the transverse processes at the back of the spine.

References

1. Combined effect of DBM, PRP, and bone marrow fluid on bone union in a rat posterolateral fusion model. Scientific Reports (2023).
2. A systematic review and meta-analysis of fusion rate enhancements and bone graft options for spine surgery. Scientific Reports (2022).
3. Advances in implants and bone graft types for lumbar spinal fusion surgery. Biomaterials Science (2024).
4. Mesenchymal Stem Cell Exosomes Enhance Posterolateral Spinal Fusion in a Rat Model. Cells (2024).
5. Safety and efficacy of autologous bone marrow clot as a multifunctional bioscaffold for instrumental posterior lumbar fusion: a 1-year follow-up pilot study. Frontiers in Endocrinology (2024).